As Parkinson’s Awareness Month comes to a close, the urgency to challenge the status quo has never been greater. With nearly ...
Last month marked Women’s History Month, and in February there was International Day of Women and Girls in Science, too. But, ...
Clinical trial sponsors and contract research organisations (CROs) are expanding clinical trials internationally to access ...
Oligonucleotide (oligo) therapies have been in development for decades. Recent advances in molecular design, chemistry, ...
The regulator has sent a complete response letter (CRL) to AbbVie for trenibotulinumtoxinE (TrenibotE), a follow-up to its ...
In addition to the three NPVs, the FDA also announced the approval of an IND submission for DemeRx, which is investigating ...
Berkeley, California biotech Ray Therapeutics, a specialist in the development of optogenetic therapies for eye disorders, ...
In biotech, value is created at discrete moments – when data resolves uncertainty. Until then, risk remains. Every dollar ...
In this week's second major AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, designed to ...
The Telethon Undiagnosed Diseases Programme (TUDP), run by the Naples-based biomedical charity Fondazione Telethon, has ...
The phase 3 LITESPARK-012 trial is testing triplet therapy with oral HIF-2 alpha inhibitor Welireg (belzutifan) given ...
Regeneron has become the first company to get US approval for a gene therapy for congenital hearing loss, after the FDA gave ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results